Minimally invasive thoracic surgery has advanced the treatment of lung cancer since its introduction in the 1990s. Video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS) offer the advantage of smaller incisions without compromising patient outcomes. These techniques have been shown to be safe and effective in standard pulmonary resections (lobectomy and sub-lobar resection) and in complex pulmonary resections (sleeve resection and pneumonectomy). Furthermore, several studies show these techniques enhance patient outcomes from early recovery to improved quality of life (QoL) and excellent oncologic results. The rise of RATS has yielded further operative benefits compared to thoracoscopic surgery. The wristed instruments, neutralization of tremor, dexterity, and magnification allow for more precise and delicate dissection of tissues and vessels. This review summarizes of the advancements in minimally invasive thoracic surgery and the positive impact on patient outcomes.
自20世纪90年代问世以来，微创胸外科手术推动了肺癌治疗的进步。电视辅助胸腔镜手术（VATS）与机器人辅助胸外科手术（RATS）在保证治疗效果的同时，具有切口更小的优势。研究证实这些技术在标准肺切除术（肺叶切除及亚肺叶切除）和复杂肺切除术（袖状切除及全肺切除）中均安全有效。多项研究还表明，这些技术能改善患者预后，从早期康复到生活质量提升，乃至获得良好的肿瘤学结果。相较于胸腔镜手术，机器人辅助胸外科手术的兴起带来了更多手术优势：其腕式器械、震颤过滤功能、灵活操作性和放大视野，实现了对组织与血管更精准细致的解剖。本文综述了微创胸外科手术的进展及其对患者预后的积极影响。
肿瘤(癌症)患者之家